INFUSE Multifocal from Bausch + Lomb Corp. - daily disposable lens for presbyopia

Reviewed: ad hoc news New Release & Launch desk. Edited and checked on 2026-06-24, 00:27. Details in the imprint.

INFUSE Multifocal from Bausch + Lomb sits between finger and thumb with a slight shimmer, then almost disappears once it touches the eye. The daily disposable contact lens is aimed at people with presbyopia who hop constantly between smartphone, laptop and street signs.

New daily option for presbyopia

Bausch + Lomb positions INFUSE Multifocal as a silicone hydrogel daily disposable designed for emerging and existing presbyopes who spend long hours on digital devices. The company highlighted the product launch in its official press release.

The lens uses what Bausch + Lomb calls ProBalance Technology, combining a particular polymer mix with electrolytes and moisturizers intended to help maintain ocular surface homeostasis through the day. According to the official product page, the material is a high-water-content silicone hydrogel with a 55% water content.

Optics aimed at all distances

The optical design is built around a centre-near aspheric multifocal profile, which should support near work like reading a menu while preserving intermediate and distance vision. Eye-care professionals such as Dr. Sheila Morrison in early US launch communications describe the lens as a practical option for patients who complain about digital eye fatigue yet dislike readers.

Comfort details in daily use

The lens edge feels smooth when slid gently under a fingernail, and wearers in early practitioner feedback describe a quiet first fit without the scratch that some older multifocals can cause during insertion. The design is aimed at maintaining comfort up to 16 hours for many users, depending on tear film and environment.

Bausch + Lomb integrates several ingredients, including potassium and pro-vitamin B5, in the packaging solution to support the corneal surface as wear begins. That cocktail is meant to complement the silicone hydrogel material, which allows high oxygen transmissibility while keeping the lens surface reasonably wettable over the day, especially in air-conditioned offices.

Availability, pricing and markets

INFUSE Multifocal is being rolled out first in North America via eye-care professionals, with Bausch + Lomb focusing on prescription channels rather than online-only sales. Pricing is set by individual practices, but the lens sits in the premium daily disposable range, typically above traditional hydrogel multifocals.

For Germany and wider Europe, Bausch + Lomb is still building out the INFUSE family, while the enVista Envy intraocular lens and other presbyopia solutions take the lead in surgical channels. Reuters recently reported on the company expanding its presbyopia portfolio in Europe with different lens technologies.

Context for investors

Overall, INFUSE Multifocal underlines how Bausch + Lomb is filling gaps between simple sphere daily lenses and more complex presbyopia and astigmatism corrections. For investors, it is one more SKU in a broad vision-care lineup anchored by contact lenses, lens care and surgical products, while prescription medicines add another leg of growth.

Bausch + Lomb Corp shares (ISIN CA07174N1090) trade on the New York Stock Exchange, giving international investors exposure to the contact lens and eye-health franchise built around products such as INFUSE Multifocal.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.